QIAGEN NV Forecast, price target & analysts
QIAGEN NV Target price 2026 - Analyst rating & recommendation
QIAGEN NV Classifications & Recommendation
QIAGEN NV Price Target
| Target Price | $47.43 |
| Price | $44.75 |
| Potential |
5.99%
register free of charge
|
| Number of Estimates | 18 |
|
18 Analysts have issued a price target QIAGEN NV 2027 .
The average QIAGEN NV target price is $47.43.
This is
5.99%
register free of charge
$53.01
18.47%
register free of charge
$40.40
9.72%
register free of charge
|
|
| A rating was issued by 23 analysts: 11 Analysts recommend QIAGEN NV to buy, 12 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the QIAGEN NV stock has an average upside potential 2027 of
5.99%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.09 | 2.18 |
| 5.65% | 4.21% | |
| EBITDA Margin | 26.77% | 36.49% |
| 4.95% | 36.32% | |
| Net Margin | 20.33% | 23.78% |
| 381.10% | 16.97% |
25 Analysts have issued a sales forecast QIAGEN NV 2026 . The average QIAGEN NV sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an QIAGEN NV EBITDA forecast 2026. The average QIAGEN NV EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 QIAGEN NV Analysts have issued a net profit forecast 2026. The average QIAGEN NV net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.94 | 2.51 |
| 385.00% | 29.38% | |
| P/E | 17.84 | |
| EV/Sales | 4.62 |
24 Analysts have issued a QIAGEN NV forecast for earnings per share. The average QIAGEN NV EPS is
This results in the following potential growth metrics and future valuations:
Current QIAGEN NV Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jun 23 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | May 18 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | May 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jun 23 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
May 18 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
May 07 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
